Imunon, Inc. Restricted Stock or Unit Expense
Imunon, Inc. (IMNN) reported Restricted Stock or Unit Expense of $171.55 thousand for the 12-month period ending 2011-12-31, per its 10-K/A filed 2012-03-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2012-03-15
- Imunon, Inc. restricted stock or unit expense for fiscal 2011 was $171.55K, a 52.04% decline from fiscal 2010.
- Imunon, Inc. restricted stock or unit expense for fiscal 2010 was $357.68K.
| Period end | Restricted Stock or Unit Expense 12 month |
|---|---|
| 2011-12-31 | $171.55K 10-K/A · filed 2012-03-15 |
| 2010-12-31 | $357.68K 10-K/A · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |